ONCOLYTICS BIOTECH INC (ONCY) Stock News

USA - NASDAQ:ONCY - CA6823108759 - Common Stock

1.16 USD

-0.01 (-0.85%)

Last: 10/30/2025, 8:00:02 PM

1.18 USD

+0.02 (+1.72%)

After Hours: 10/30/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ONCY Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Oncolytics Biotech® Inc.

Oncolytics Biotech® Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care

11 days ago - By: Oncolytics Biotech® Inc.

Oncolytics Biotech® Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada

3 months ago - By: Benzinga

What to Expect from Oncolytics Biotech's Earnings

21 days ago - By: Benzinga - Mentions: IVA ARAY KIDS VNRX ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

a month ago - By: Oncolytics Biotech® Inc.

Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study

a month ago - By: Oncolytics Biotech® Inc.

Oncolytics Biotech® Provides Update on GOBLET Study Progress and U.S. Site Expansion

2 months ago - By: Oncolytics Biotech® Inc.

Oncolytics Biotech® Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions

2 months ago - By: Oncolytics Biotech® Inc.

Oncolytics Biotech® Provides Updated Clinical Safety Data for Pelareorep, Including Across Multiple Gastrointestinal Tumors

2 months ago - By: Oncolytics Biotech® Inc.

Oncolytics Biotech® Announces Upcoming Investor Conferences in September

3 months ago - By: Oncolytics Biotech® Inc.

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders

3 months ago - By: Oncolytics Biotech® Inc.

Oncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep

3 months ago - By: Oncolytics Biotech® Inc.

Oncolytics Biotech® Announces Voluntary Delisting from the Toronto Stock Exchange

3 months ago - By: Oncolytics Biotech® Inc.

Oncolytics Biotech® Announces Upcoming Annual General Meeting and Second Quarter Financial Results